United States · Funded startup

Who invested in Inozyme

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$60Mraised across 1 round since 2023, from 1 source

Latest round
Round, $60MJul 2023
Investors
4
See who backed them

The rounds

  1. Jul 2023

Everyone who backed them

RA Capital ManagementPrivate equity1round
Novo HoldingsVC firm1round
SanofiInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Inozyme as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Longitude CapitalVC firmPer its own site

Quick answers about Inozyme

Who invested in Inozyme?

Inozyme's investors include New Enterprise Associates, RA Capital Management, Novo Holdings and Sanofi.

How much has Inozyme raised?

Inozyme has raised $60M across 1 round since 2023.

When did Inozyme last raise?

Inozyme's most recent round was an Undisclosed round of $60M in Jul 2023.

What was Inozyme's biggest round?

Its most recent round, $60M in Jul 2023, is also its largest on record.

Who backed Inozyme first?

Inozyme's first round on record, in Jul 2023, was backed by New Enterprise Associates, RA Capital Management and Novo Holdings and 1 others.

What stage is Inozyme at?

Inozyme's latest named round is an Undisclosed round, in Jul 2023.

Where is Inozyme based?

Inozyme is based in the United States.

Companies like Inozyme

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.